ALS Center of Excellence

Pranger ALS Clinic

  • Home
  • About
    • What Is ALS?
    • Scott L. Pranger
    • National Advisory Board
    • Faculty & Staff
    • ALS Center of Excellence Brochure
  • Clinic
    • Services
    • Your Visit to the ALS Clinic
    • Patient Portal
    • Durable Medical Equipment
    • Frequently Asked Questions
  • Research
    • Clinical Trials
    • Observational Studies
    • Participate in Research at U-M
  • News
  • Patient Care Guide
    • Living with ALS
    • Nutrition
    • Patient & Family Support
  • Contact
  • NeuroNetwork
  • Make A Gift

Latest News

ALS Risk Higher Among Production Workers

… [Read More...]

“Research Into Preventing ALS…”

… [Read More...]

portrait of Dr. Eva Feldman in her lab

Dr. Feldman Given Highest University of Michigan Honor

… [Read More...]

Multidisciplinary Team Publishes Paper on ALS Occupational Risk

… [Read More...]

The ANA Q&A: Dr. Eva Feldman on ALS

… [Read More...]

Claudia Figueroa-Romero, PhD, and Benjamin Murdock, PhD, Interviewed and Published in Disease Models & Mechanisms

November 22, 2019

Assistant Research Scientist Claudia Figueroa-Romero, PhD, and Research Assistant Professor Benjamin Murdock, PhD, are co-first authors of a paper that found an association between gut bacteria and the immune system during ALS progression in a mouse model. They found that changes in gut bacteria preceded alterations in the immune system. This could drive future research aimed at understanding the timing that ALS progresses as it relates to gut bacteria and immune system changes. It suggests that there could be specific time windows when treatments could be implemented to modify gut bacteria and/or the immune system to slow the disease.

Drs. Murdock and Figueroa-Romero

Drs. Figueroa-Romero and Murdock were highlighted by the publishing journal, Disease Models & Mechanisms, with a “First Person” interview, which includes further insights into what this work could mean to future ALS research. Read an excerpt below and find the full article HERE.

What are the potential implications of these results for your field of research?

CFR+BM: Both bacterial communities and immune changes have been previously implicated in ALS progression. Defining the temporal occurrence and interrelation of these pathological processes may identify specific windows when the disease may be treated with specific therapies. In addition, because of the strong link between the microbiome and the immune system, we may be able to modulate the impact of the immune system in ALS by changing the microbiome: probiotics, fecal transplants, etc. may be viable therapeutic options to slow ALS progression.

“Temporal evolution of the microbiome, immune system and epigenome with disease progression in ALS mice” was published in November 2019. The article is available HERE.

Share this:

  • Facebook
  • Twitter
  • LinkedIn

Filed Under: News, Press

Newsletter Signup

Subscribe to our mailing list for updates regarding our clinic and research

Click Here for the ALS Registry

ALS Center of Excellence at Michigan Medicine ALS Infographic

ALS Brochure

ALS Brochure

 

 

 

 

 

Resources

Organizations

  • ALS Association
  • ALSA-Michigan Chapter
  • Ann Arbor Active Against ALS
  • ALSA-Northern Ohio Chapter
  • ALS of Michigan
  • National ALS Registry
  • Northeast ALS Consortium
  • Muscular Dystrophy Association

Services

  • Veterans Benefits
  • Social Security Benefits

Useful Links

  • U-M Stem Cell Research
  • Center for Stem Cell Biology
  • Human Embryonic Stem Cell Research
  • Society for Stem Cell Research

RSS Research News

  • U-M to establish new Institute for Firearm Injury Prevention
  • U-M Depression Center to be named for Eisenberg family, in recognition of $30M in giving
  • Research on aging expands at U-M with $15M in new grants

Contact Information

Michigan Medicine
1500 E. Medical Center Drive
Ann Arbor, MI 48109
Phone: 734-936-4000
Contact Michigan Medicine

Connect With Us

Copyright © 2023 Regents of the University of Michigan · Disclaimer · Privacy Statement

  • About UMHS
  • For Patients
  • For Health Professionals
  • For Researchers
  • Home
  • About
    ▼
    • What Is ALS?
    • Scott L. Pranger
    • National Advisory Board
    • Faculty & Staff
    • ALS Center of Excellence Brochure
  • Clinic
    ▼
    • Services
    • Your Visit to the ALS Clinic
    • Patient Portal
    • Durable Medical Equipment
    • Frequently Asked Questions
  • Research
    ▼
    • Clinical Trials
    • Observational Studies
    • Participate in Research at U-M
  • News
  • Patient Care Guide
    ▼
    • Living with ALS
    • Nutrition
    • Patient & Family Support
  • Contact
  • NeuroNetwork
  • Make A Gift